Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diet or diuretics for salt sensitivity in chronic kidney disease
NL-OMON43616Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrochlorothiazide, amiloride and sodium chloride in hypertension (HTN) and chronic kidney disease (CKD), sponsored by Erasmus MC. Started Jun 2016; status: active, not recruiting.
02
Drugs
hydrochlorothiazideamiloridesodium chloride
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NL-OMON43616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43616.